Completed NA INTERVENTIONAL 2-arm NCT00614848

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions

Sponsor: Medtronic Vascular

Conditions Arterial Occlusive Diseases Arteriosclerosis Coronary Arteriosclerosis Coronary Artery Disease Coronary Disease Heart Diseases Ischemia Myocardial Ischemia Vascular Diseases

Interventions Endeavor drug eluting coronary stent

Updated 5 times since 2017 Last updated: Apr 8, 2011 Started: Jun 30, 2003 Primary completion: Jan 31, 2005 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Arterial Occlusive Diseases and Arteriosclerosis, this trial is completed. The trial is conducted by Medtronic Vascular and has accumulated 5 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Vascular

Data source: Medtronic Vascular

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Clinique Pasteur, France